ICU Medical, Inc. announced its financial results for the third quarter ended September 30, 2024, reporting total revenue of $589.1 million. This represents a 6.5% increase compared to $553.3 million in the same period of the prior year, demonstrating continued demand for the company's medical devices.
The company posted a GAAP gross profit of $204.9 million for the quarter, an increase from $183.9 million in Q3 2023. Despite this, ICU Medical reported a GAAP net loss of $(33) million, or $(1.35) per diluted share, while adjusted diluted earnings per share stood at $1.59.
ICU Medical also stated it updated its fiscal year 2024 guidance, reflecting management's revised outlook for the remainder of the year based on current business conditions. The revenue growth and adjusted earnings provide key indicators of the company's operational performance and strategic progress.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.